Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
TORI inks agreement with company formerly known as ChromaVision
May 12th, 2005
Clarient, Inc., (CLRT) announced that it has entered into an agreement with Translational Oncology Research International (TORI) under which Clarient's BioAnalytical Services business unit will provide various biopharmaceutical research services for TORI-sponsored studies. TORI is devoted to evaluating agents for cancer treatment. Clarient, formerly known as ChromaVision Medical Systems, is a provider of automated cell-imaging systems and advanced oncology laboratory services. "We are delighted with the opportunity to offer our lab services expertise and diagnostic technologies to support TORI in breast cancer clinical trials," said Kenneth D. Bauer,...
Source: Women's Health Weekly (2005-05-12)
|
